Mabel - About the company
Mabel is an unfunded company based in Gothenburg (Sweden), founded in 2022. It operates as a Developer of real-time translation system for healthcare and public sector. Mabel has not raised any funding yet. The company has 20 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like MediPhone, No Barrier AI and Switchboard, MD.
Company Details
Developer of real-time translation system for healthcare and public sector. The system offers fluent voice-to-voice conversation across language barriers with instant verification. It features domain-specific and customized vocabulary, along with automated documentation. The translation system runs on-device, on-premise, or in a data center. It provides accessible, confidential translation, and transcription.
- Website
- mabel.care
Key Metrics
Founded Year
2022
Location
Gothenburg, Sweden
Stage
Unfunded
Ranked
16th among 20 active competitors
Similar Companies
Sign up to download Mabel's company profile
Mabel's funding and investors
Mabel has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Mabel's Competitors and alternates
Top competitors of Mabel include MediPhone, No Barrier AI and Switchboard, MD. Here is the list of Top 10 competitors of Mabel, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of medical translator services and software for healthcare organizations | $8.13M | 46/100 | ||
2nd | No Barrier AI 2023, San Francisco (United States), Seed | Provider of AI powered medical interpreter | $2.7M | 40/100 | |
3rd | Switchboard, MD 2022, Atlanta (United States), Unfunded | Language translation solutions for healthcare organizations | - | - | 36/100 |
4th | Jaide Health 2023, Boston (United States), Funding Raised | AI driven platform for foreign language medical interpretation and translation | - | - | 32/100 |
5th | Vocality Health 2025, Denver (United States), Seed | AI powered medical language interpretation platform | $500K | 29/100 | |
6th | AI-based voice recognition tool for medical professionals | - | - | 26/100 | |
7th | uCareLINGO 2020, Toronto (Canada), Unfunded | Provides AI-based voice translation app for healthcare providers | - | - | 24/100 |
8th | MedicTranslate 2023, Kobe (Japan), Unfunded | Provider of AI-based medical translation services | - | - | 24/100 |
9th | Medical Narration 2012, Orange (United States), Unfunded | Provider of male & female narration voice overs for medical training resources | - | - | 24/100 |
10th | JuicerScribe 2025, San Francisco (United States), Unfunded | Provider of a transcription platform that converts audio streams into searchable text | - | - | 24/100 |
16th | Developer of real-time translation system for healthcare and public sector | - | - | 16/100 |
Looking for more details on Mabel's competitors? Click here to see the top ones
Mabel's Investments and acquisitions
Mabel has made no investments or acquisitions yet.
Reports related to Mabel
Here is the latest report on Mabel's sector:
Are you a Founder ?
FAQs about Mabel
Explore our recently published companies
